KDM3A and Miyoshi myopathy: Ohguchi et al. [19] identified a KDM3A-KLF2-IRF4 axis that maintained myeloma cell survival and dysfunction of KDM3A (a chromatin remodeler) was toxic to MM cells in vitro and in vivo.